Ann: GMP Tablet Manufacture Commences for Canine Clinical Trials, page-19

Thanks for letting us know about the up coming Interview,, look forward to that,, hopefully the company can convey their message clearly , simply and informatively.

Being able to communicate to market "When" the Trials Begin, "What" the Duration is , "Why" the data is so important , plus the market still hasn't taken the Elanco Option into Value.
The company has progressed overcoming Milestones through out the last year ,,yet the MC is half what it was?
We know the commercial application for Cancer Treatments is astronomical, so the company needs to drop the shy modest wallflower persona ,,
State the Company achievements in your best frock and slap some lippy on ... PAA need to make a splash just to have the market recognise true value,, IMHO circa 12c at present...